23andMe Files for Bankruptcy After Data Breach and Failed Expansion
Summary
Genetic testing company 23andMe, plagued by a data breach, dwindling sales, and failed forays into healthcare, filed for Chapter 11 bankruptcy, notifying customers to file potential claims by July 14 amid its restructuring and uncertain future.
Key Points
- 23andMe filed for Chapter 11 bankruptcy and notified customers of potential claims with a deadline of July 14 to file
- The bankruptcy followed a data breach, declining sales, and costly expansion into digital health and telemedicine
- Customers affected by the data breach or with other grievances can file claims as part of the bankruptcy case